Preparation method of lacrimal duct plug with medicine slow release function

A technology of lacrimal canaliculus and function, applied in the field of polymer material preparation, can solve the problems of body rejection, poor biocompatibility, secondary damage, etc., and achieve the effects of reducing rejection and inflammation, convenient modification, and strong mechanical properties

Inactive Publication Date: 2018-08-14
广州锐澄医疗技术有限公司
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, silica gel is the raw material and is hydrophobic. It needs lubricating oil to assist in implantation, and the implantation period generally does not exceed one month. Therefore, it needs to be replaced after the expiration date, and it needs to be removed by a second operation. Secondary damage often occurs, leading to bleeding, inflammation, etc. reaction, resulting in granulation hyperplasia and other phenomena
There are also lacrimal canaliculus plugs obtained from materials such as polydioxanone, acrylic acid, and medical silicone rubber. The biocompatibility of this type of material is relatively poor, and long-term implantation is likely to induce body rejection and chronic inflammation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of lacrimal duct plug with medicine slow release function
  • Preparation method of lacrimal duct plug with medicine slow release function
  • Preparation method of lacrimal duct plug with medicine slow release function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] An embodiment of the preparation method of the lacrimal canaliculus plug with drug sustained release function according to the present invention, comprising the following steps:

[0033] (1), the preparation raw material of punctum plug is mixed uniformly, injects in the mould;

[0034] (2), react the mold at 50°C for 24 hours, solidify and form, and obtain a preliminary formed hydrogel;

[0035] (3), place the preliminary formed hydrogel obtained in step (2) in a UV curing machine, irradiate with ultraviolet light for 10 minutes, and further solidify and form to obtain a formed hydrogel;

[0036] (4), the formed hydrogel obtained in step (3) is taken out from the mold, soaked and washed with clear water for 3 days, taken out, and dried to obtain the lacrimal canaliculus plug with drug sustained release function;

[0037] Wherein, the raw materials for the preparation of the lacrimal canaliculus plug include the following components in parts by weight: 50 parts of hydr...

Embodiment 2

[0042]An embodiment of the preparation method of the lacrimal canaliculus plug with drug sustained release function according to the present invention, the difference between the preparation method of the lacrimal canaliculus plug described in this example and Example 1 is that the raw materials for the preparation of the punctum plug are heated The ratio of initiator and photoinitiator is different, and the lacrimal plug described in this embodiment contains the following preparation raw materials in parts by weight: 50 parts of hydroxyethyl methacrylate, 10 parts of polyethylene glycol diacrylate, ethylene dimethacrylate 10 parts of alcohol ester, 50 parts of water, 6 parts of photoinitiator and 6 parts of thermal initiator;

[0043] The photoinitiator is a mixture of 2-hydroxyl-2-methylpropiophenone and 2,4,6-trimethylbenzoyl-diphenylphosphine oxide; the 2-hydroxyl-2-methylpropiophenone and 2,4,6-trimethylbenzoyl-diphenylphosphine oxide in a weight ratio of 2-hydroxy-2-meth...

Embodiment 3

[0046] An embodiment of the preparation method of the lacrimal canaliculus plug with drug sustained release function according to the present invention, the difference between the preparation method of the lacrimal canaliculus plug described in this example and Example 1 is that the raw materials for the preparation of the punctum plug are heated The ratio of initiator and photoinitiator is different, and the lacrimal plug described in this embodiment contains the following preparation raw materials in parts by weight: 50 parts of hydroxyethyl methacrylate, 10 parts of polyethylene glycol diacrylate, ethylene dimethacrylate 10 parts of alcohol ester, 50 parts of water, 8 parts of photoinitiator and 4 parts of thermal initiator;

[0047] The photoinitiator is a mixture of 2-hydroxyl-2-methylpropiophenone and 2,4,6-trimethylbenzoyl-diphenylphosphine oxide; the 2-hydroxyl-2-methylpropiophenone and 2,4,6-trimethylbenzoyl-diphenylphosphine oxide in a weight ratio of 2-hydroxy-2-met...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of a lacrimal duct plug with a medicine slow release function. The method comprises the following steps of (1) uniformly mixing preparation raw materials of the lacrimal duct plug; injecting the materials into a mold; (2) performing reaction for 18 to 26h in the mold at 25 to 88 DEG C; performing curing shaping to obtain primarily shaped water gel; (3)performing UV irradiation on the primarily shaped water gel obtained in the step (2) for 5 to 30 min; performing further curing and shaping to obtain shaped water gel; (4) taking out the shaped watergel obtained in the step (3) from the mold; performing soaking and washing for 2 to 4 days by clean water; then, taking out the water gel; performing drying; obtaining the lacrimal duct plug with themedicine slow release function. The lacrimal duct plug uses hydroxyethyl methacrylate as a substrate; the medicine can be loaded; after the implementation by operation, the water absorption expansioncan be realized; the self fixing effect is achieved; the operative operation is facilitated; the medicine release speed can be regulated in a controllable way; the long-time implementation can be realized; the repulsion and the inflammation can be reduced; the excellent biocompatibility is realized.

Description

technical field [0001] The invention relates to a preparation method of a polymer material, in particular to a preparation method of a lacrimal canaliculus plug with drug sustained release function. Background technique [0002] Dry eye, also known as keratoconjunctival sicca, refers to a class of diseases that cause ocular discomfort symptoms due to tear film instability and ocular surface damage caused by abnormal tear quality and quantity or tear fluid dynamics. The clinical symptoms of dry eye usually manifest as dryness, foreign body, pain, burning, itching, blurred vision, red eyes, photophobia, tearing, etc. Lacrimal canalicular embolization using various emboli is a relatively new technique for sealing the lacrimal duct. By mechanically blocking the lacrimal duct, the discharge of tear fluid is reduced, the balance of tear fluid on the ocular surface is re-established, and the environment of the ocular surface is improved, thereby significantly reducing the pain of p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C08F283/06C08F220/20C08F2/48A61L24/00A61L24/06
CPCA61L24/001A61L24/0015A61L24/0036A61L24/06A61L2300/602C08F2/48C08F283/065C08F220/20C08L51/08
Inventor 曾晨光李锐聪杨习锋郭少成
Owner 广州锐澄医疗技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products